Public

Respiratory Medication Therapy Adherence Clinic Protocol: Asthma/COPD (Adult & Paediatric) 2nd Edition 2015

Taking into account changes in current practice and the introduction of newer medicines and devices used in the management of asthmatic and Chronic Obstructive Pulmonary Disorder (COPD) patients, it is timely to review and publish this second edition of Respiratory Medication Therapy Adherence Clinic (RMTAC) Protocol. This updated protocol will also help ensure the standardisation of practice and contribute towards the expansion of RMTAC service throughout Ministry Of Health facilities; both in primary and secondary care settings.

 

English

Garis Panduan untuk Pemantauan Keselamatan Produk Erythropoietin Stimulating Agents (ESAs) & Pelaporan Kesan Advers Pure Red Cell Aplasia (PRCA)

Pure Red Cell Aplasia (PRCA) is one of the adverse effects due to usage of Erythropoietin Stimulating Agents (ESAs).  The definition for PRCA is as follows:

‘Epoiten-associated pure red cell aplasia (PRCA) is characterized by severe anemia, low reticulocyte count, erythroblasts absence, epoetin non-response, and neutralizing antibodies against erythropoietin (EPO).  PRCA is a rare adverse effect resulting from antibodies to Erythropoietin Stimulating Agents (ESAs) that cross-react with endogenous erythropoietin.’

English

9th National Pharmacy R&D Conference 2016 (2nd Announcement)

Location/place: 
Kuala Lumpur/Putrajaya
Date: 
Monday, 8 August 2016 to Wednesday, 10 August 2016

National Antimicrobial Guideline (NAG) 2024, 4th Edition

The National Antimicrobial Guideline (NAG) is an important reference to ensure rational use of antimicrobials which in turn will reduce the risk of antimicrobial resistance.

English

Diabetes Medication Therapy Adherence Clinic Protocol, Third Edition 2022

Over the time span of a decade, Diabetes Medication Therapy Adherence Clinic (DMTAC) service has expanded and extended throughout the nation and has remained as one of the major MTAC in the Ministry of Health's (MOH) facilities. Hence, it is timely to review and publish this third edition of DMTAC

English

Guidelines on Approval and Recognition of A Pharmacy Programme

The purpose of this document is to provide guidelines to both public and private institutions for preparing institutional databases and self-study reports for application for recognition/accreditation of pharmacy degree programmes. The Pharmacy Board Malaysia and National Accreditation Board (NAB) / Malaysian Qualification Agency (MQA) use these guidelines for assessing each application for recognition/accreditation status. The guidelines are neither prescriptive nor too rigid as to stifle initiative, development and expansion of the pharmacy field.

Retroviral Disease (RVD) Pharmacy Services Protocol: Adult and Paediatric (Third Edition)

The RVD Pharmacy Services Protocol provides a structured guideline for pharmacists to initiate, deliver, and monitor pharmaceutical care related to RVD therapy in both inpatient and outpatient settings.

English

BPF Portal with a fresh new look

Selamat datang

Welcome to the all-new BPF Portal!

BPF Portal is now further refining the content, layout and functions in order to give only the best for you. Here are some of the new features that are included in the new BPF Portal:

Garis Panduan Latihan Sangkutan Pegawai Farmasi, Lantikan Preseptor dan Pusat Latihan dalam Bidang Pengkhususan Farmasi Klinikal atau Farmasi Klinikal dan Teknikal (Edisi 2025)

The Garis Panduan Latihan Sangkutan Pegawai Farmasi, Lantikan Preseptor dan Pusat Latihan dalam Bidang Pengkhususan Farmasi Klinikal atau Farmasi Klinikal dan Teknikal (Edisi 2025) serves as an update of the guideline previously published in 2018. This document aims to provide comprehensive guidance on the procedures related to pharmacist training in the field of clinical pharmacy or clinical and technical pharmacy.

English

Guideline for the Ministry of Health Malaysia Drug Formulary (FUKKM), Fourth Edition (2025)

This guideline serves as a reference for all healthcare personnel across hospitals, clinics and institutions under the Ministry of Health Malaysia (MOH) regarding the use of the MOH Drug Formulary and matters related to formulary management within MOH facilities.

English

Pages